Search

Your search keyword '"Haseeb, Abdul"' showing total 20 results
Start Over Author "Haseeb, Abdul" Journal cureus
20 results on '"Haseeb, Abdul"'

3. Unveiling Sex Differences in Tricuspid Valve Disease: A Systematic Review and Meta-Analysis of Surgical Management

Author

Khan, Ayesha Islam, primary, Surve, Tahoora N, additional, Senthilkumar, Virushnee, additional, Kumar, Nishant, additional, Haseeb, Abdul, additional, Bosco, Shinto, additional, Tirupati, Soujanya, additional, Ramalingame, Rajeswari, additional, Thaher, Asem M, additional, Alasaadi, Saya, additional, and Suleman, Umer, additional

Published
2023
Full Text
View/download PDF

14. Factors Determining Pakistani Medical Students’ Career Preference for General Practice Residency Training

Author

Bilal, Muhammad, primary, Haseeb, Abdul, additional, Mari, Anum, additional, Hussham Arshad, Mohammad, additional, Ali Khan, M.Raafe, additional, Ahmed, Ayesha, additional, Jeoffrey, Ramsha, additional, Saleem, Zainab, additional, Irfan, Muhammad Abrar, additional, Aamir Khan, Arsalan, additional, Husain, Sana, additional, Najeeb, Simrah, additional, Fuad Garib, Amal, additional, Mustafa Attarwala, Fatema, additional, and Hasnain Mankani, Muhammad, additional

Published
2018
Full Text
View/download PDF

15. Knowledge, Attitudes, and Practices Among Nurses in Pakistan Towards Diabetic Foot

Author

Bilal, Muhammad, primary, Haseeb, Abdul, additional, Rehman, Abdur, additional, Hussham Arshad, Mohammad, additional, Aslam, Aashir, additional, Godil, Sana, additional, Qamar, Mohammad A, additional, Husain, Saif N, additional, Polani, Muhammad H, additional, Ayaz, Araib, additional, Ghazanfar, Altamash S, additional, Ghazali, Zaki M, additional, Khoja, Khurram A, additional, Malik, Maarij, additional, and Ahmad, Hania, additional

Published
2018
Full Text
View/download PDF

16. Frequency and Determinants of Inappropriate Use of Treadmill Stress Test for Coronary Artery Disease

Author

Bilal, Muhammad, primary, Haseeb, Abdul, additional, Arshad, Mohammad H, additional, Jaliawala, Altamash A, additional, Farooqui, Iman, additional, Minhas, Amna, additional, Hussaini, Ahmedullah, additional, Khan, Arsalan A, additional, Ahmad, Sharjeel, additional, Saleem, Zainab, additional, Awan, Ozair, additional, Sabahat, Noor Us, additional, Ayaz, Araib, additional, and Rizwan, Haania, additional

Published
2018
Full Text
View/download PDF

20. Unlocking the Therapeutic Symphony: A Systematic Review Exploring the Role of Levosimendan in the Management of Heart Failure.

Author

Ali R, Sajjad W, Mushtaq I, Farooqi H, Sohail A, Wazir Khan H, Tabasum P, Haseeb A, and Ismail WU

Abstract

Levosimendan, a novel drug, a calcium-sensitizing inotrope, has emerged as a potential therapeutic modulator for heart failure (HF). This review appraises the efficacy and safety of levosimendan in managing HF, in different clinical settings. The study aims to examine the clinical outcomes reported in the selected trials to determine the effectiveness of levosimendan in improving key parameters related to HF. Seven relevant studies encompassing 1200 participants were identified from three databases. Inclusion criteria included clinical trials that investigated the therapeutic efficacy of levosimendan in the treatment of HF, and studies involving both adult and pediatric participants. Exclusion criteria involved studies with insufficient data, studies other than clinical trials, case reports, letters to the editor, conference papers, grey literature, and studies published in a language other than English. Upon evaluating the included studies, it was found that levosimendan shows improved hemodynamics and clinical efficacy in patients with severe septic cardiomyopathy. Levosimendan enhanced right ventricular (RV) function in patients with RV dysfunction after mitral valve (MV) surgeries and decreased the amount of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) in non-ST elevated myocardial infarction (NSTEMI) patients with elevated NT-proBNP, all without increasing the overall cost or duration of hospitalization. Despite variations in study designs and participant characteristics, evidence suggests levosimendan significantly improves left ventricular ejection fraction (LVEF) and exercise tolerance measured by a six-minute walk distance. Notably, its safety profile appears favorable with minimal arrhythmic events and comparable rates of adverse effects to a placebo. This systematic review highlights levosimendan's promising potential for HF management, warranting further research to solidify its clinical role., Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Ali et al.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results